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  Serum magnesium concentration was determined pre一 and post－operatively in 57 patients
with primary hyperparathyroidism．
  No consistent abnormality of the serum magnesium level was found except for four cases
who showed hypomagnesemia． lt may be noteworthy that these four cases were psychologically
disturbed during the period when their serum magnesium levels were low．
  Renal excretion of magnesium was consistently and significantly increased over th’e normal
range．
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Fig． 1 The normal serum magnesium range of 1．8±O．3mEq／1 （2 S．D．）
   was based on duplicate analyses of 85 samples of blood ebtained
   from normal human beings from the Blood Bank． The Chart
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Fig．2（第1群） Patients with hyperparathyroidism having bone disease
      and or elevated alkaline phoshatase but no renal impair－
      ment （！6 patients＞．
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Fig．3（第2群）Patients with hyperparathyroidism having kidney stones
      without renal impairment and no demonstrable bone disease
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Fig．4（第3群） Patients with hyperparathyroidism having impaired renal
      function but with normal blood serurn uric acid levels
       （12 patients）．
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Fig．5（第4群） Patients with hyperparathyroidisrn haVing elevated serum
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Fig。6（第5群）Patients with hyperparathyroidism with miscellaneous
       troubles （peptic ulcer． pancreatitis， nervous system disor－
       ders） but none of the disorders of the patients in Fig． 2， 3，
       4 and 5 （4 patients）．
 H．マグネシウム制限食によるMg排泄量
 既述のごとく，Barnes et aL（1957）の方法に従っ
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Fig． 7 The urinary excretion of 12 normal
   controls on the low magnesium diet，
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Fig． 8 The urinary excretion of 8 patients
   with hyperparathyroidsm on a low
   magnesium diet， range and averages．
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Fig． 9 The fecal content of 11 normal cont－
   rols on the low magnesium diet， range








Fig．10 The fecal content of 7 patients with
   hyperparathyroidism on a low magne－
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